After establishing the benign nature of a gastric ulcer, the treatment
is primarily medical. This medical therapy is aimed to alleviate symp
toms, to heal the ulcer and to prevent relapses. Based on the history
of non-steroidal anti-inflammatory drugs (NSAIDs) and the Helicobacter
pylori-status, gastric ulcer patients can be divided into four catego
ries (1) H. pylori positive plus NSAID-use, (2) H. pylori positive wit
hout NSAID use, (3) NSAID use with negative H. pylori-status, (4) Nega
tive H. pylori-status and no NSAID use. Patients taking NSAIDs should
stop this therapy if possible. Patients with gastric H. pylori infecti
on should be treated by a regimen of a proton pump inhibitor with at l
east two appropriate antibiotics. This treatment will result in early
alleviation of symptoms, rapid healing of the ulcer and prophylaxis of
ulcer relapse. In patients with gastric ulcer who cannot stop NSAIDs,
maintenance therapy with prostaglandins or potent antisecretory drugs
should be considered. The few patients with gastric ulcer who do not
take NSAIDs and do not have gastric H. pylori infection should be trea
ted by antisecretory drugs, and they should be carefully followed endo
scopically to exclude malignant (carcinoma, lymphoma) or non-peptic (C
rohn's disease) disease. All patients with gastric ulcer should be re-
endoscoped to verify complete ulcer healing. Surgery may be considered
in gastric ulcer patients with complications, in those with severe dy
splasia of the gastric mucosa, and in those who are not able or willin
g to take the medication.